Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review
Bronya Calvarysky, I Dotan, Daniel Shepshelovich, et al.
Drug Safety (2024) Vol. 47, Iss. 5, pp. 439-451
Open Access | Times Cited: 16

Showing 16 citing articles:

Potential Drug Interaction Between Liraglutide and Clonazepam: A Case Report
Ali Kheradmand, Azim Mehrvar, Mohammad Abbasinazari
Case Reports in Psychiatry (2025) Vol. 2025, Iss. 1
Open Access
Medical Management of Obesity: Current Trends and Future Perspectives
Andrés Calderón, Maria Aguilera Astudillo, Alexsandra P. Rojas, et al.
Methodist DeBakey Cardiovascular Journal (2025) Vol. 21, Iss. 2, pp. 62-73
Closed Access
GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis
Levi Hooper, Shuhan Liu, Manjunath P. Pai
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2025)
Open Access
Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
Celestine I. Odigwe, Rajasekhar Mulyala, H. A. Malik, et al.
American Heart Journal Plus Cardiology Research and Practice (2025) Vol. 52, pp. 100518-100518
Open Access
Exploring Connections Between Weight‐Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database
Christophe Abi Zeid Daou, Omar Aboul Hosn, Lana Ghzayel, et al.
Endocrinology Diabetes & Metabolism (2025) Vol. 8, Iss. 2
Open Access
A Case of Pulmonary Hemorrhage, Supratherapeutic International Normalized Ratio (INR), and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Unmasking a Potential Link to Tirzepatide
Husam Shakour, Rafia Mumtaz, Edwin Feghali, et al.
Cureus (2025)
Open Access
The use of GLP-1: receptor agonist medications for benign gynecology
Matt C. Howard, Sarah E. Allen
Current Opinion in Obstetrics & Gynecology (2025)
Closed Access
On the Frontlines of Cardiovascular-Kidney-Metabolic Syndrome: A Review of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Cardiovascular and Kidney Health
Lavinia Salama, L. G. Sinn
American Journal of Health-System Pharmacy (2025)
Closed Access
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Pharmacokinetics and Toxicokinetics: Is a New Diagnostic and Therapeutic Framework Needed?
James D. Whitledge, Joseph M. Kennedy, C. James Watson, et al.
Journal of Medical Toxicology (2025)
Closed Access
Influence of glucagon‐like peptide‐1 receptor agonists on hepatic events in type 2 diabetes: a systematic review and meta‐analysis
Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 4
A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy
Carlo Maria Bellanca, Egle Augello, Giulia Di Benedetto, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Dramatic Changes in Thiopurine Metabolite Levels in a Patient With Inflammatory Bowel Disease Treated With Tirzepatide for Weight Loss
Jeremy Klein, Joëlle St‐Pierre, David Choi, et al.
ACG Case Reports Journal (2024) Vol. 11, Iss. 11, pp. e01544-e01544
Open Access | Times Cited: 1
GLP-1 receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery
Aditi Shankar, Aditi Sharma, Ariel Vinas, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
GLP1RAs have no major pharmacokinetic effect on oral medications

Reactions Weekly (2024) Vol. 1994, Iss. 1, pp. 8-8
Closed Access
Efficacy and Safety of Glp-1 Agonists on Metabolic Parameters in Non-diabetic Patients With Inflammatory Bowel Disease
Joëlle St‐Pierre, Jeremy Klein, Natalie K. Choi, et al.
Research Square (Research Square) (2024)
Open Access
Society of Family Planning Committee Statement: Contraception and body weight
Noor Zwayne, Ashley Ebersole, Jessica E. Morse, et al.
Contraception (2024), pp. 110725-110725
Closed Access
Amiodarone Therapy: Updated Practical Insights
Victorița Șorodoc, Lucia Indrei, Catinca Dobroghii, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6094-6094
Open Access
Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease
Joëlle St‐Pierre, Jeremy Klein, Natalie K. Choi, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 12, pp. 4437-4445
Closed Access
Glucagon-like peptide-1 receptor agonists in peri-operative care
Larissa Paggers, Dieter Mesotten, Hendrik Stragier
European Journal of Anaesthesiology (2024)
Closed Access
Page 1

Scroll to top